Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 12/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 6/20 | 0.67 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.51 |
| ▸ | RXRB | P28702 | 1/20 | 0.51 |
| ▸ | RXRG | P48443 | 1/20 | 0.51 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.49 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.49 |
| ▸ | AURKA | O14965 | 1/20 | 0.49 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL584599 | 0.95 | FFAR1 (0.64) | FFAR1FFAR4PLA2G4ALMNAL3MBTL1 | |
| SCHEMBL4046194 | 0.89 | FFAR1 (0.56) | FFAR1FFAR4RXRASLC13A5SERPINE1 | |
| SCHEMBL22721288 | 0.86 | FFAR1 (0.52) | FFAR1FFAR4SLC13A5LMNASERPINE1 | |
| SCHEMBL24264814 | 0.85 | HDAC3 (0.55) | FFAR1FFAR4PLA2G4ARXRA | |
| SCHEMBL30488635 | 0.84 | FFAR1 (0.54) | FFAR1FFAR4PLA2G4ALMNAL3MBTL1 | |
| SCHEMBL28018674 | 0.83 | F2RL1 (0.51) | FFAR1FFAR4PLA2G4A | |
| SCHEMBL1746676 | 0.83 | FFAR1 (0.72) | FFAR1FFAR4AKR1B1 | |
| SCHEMBL3859024 | 0.81 | FFAR4 (0.51) | FFAR1FFAR4PLA2G4ASLC13A5AURKA | |
| SCHEMBL22987222 | 0.81 | EPHX2 (0.69) | FFAR1FFAR4 | |
| SCHEMBL3533619 | 0.80 | FFAR1 (0.87) | FFAR1FFAR4RXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644321-B1 | NEW BENZAMIDES AS PPATY MODULATORS | S A L V A T LAB SA (ES) | 2011-02-09 | — | — | EP | claimed |
| US-20200275655-A1 | PYRIDINIUM SALT AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200275655-A1 | PYRIDINIUM SALT AND PEST CONTROL AGENT | PRDX1, KCNQ5, KCNQ1 | FFAR1 4048/4885FFAR4 4441/4885PLA2G4A 1524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.